Vande Casteele N, Abreu MT, Flier S, Papamichael K, et al. Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor. Clin Gastroenterol Hepatol 2022;20:465-467.
PMID: 33421628